Congressional & Regulatory Activities
A summary of Association for Clinical Oncology advocacy activities and policy recommendations are found below. We encourage our members to take action by reporting drug shortages and contacting their
Related Articles
T-DXd Plus Pembrolizumab Elicits Responses in IO-Naive HER2-Expressing or -Mutant NSCLC
Trastuzumab deruxtecan plus pembrolizumab showed early efficacy in patients with IO-naive, HER2-expressing or -mutant non–small cell lung cancer.
Foreign-trained vs US-trained doctors
A public health leader recently cited a 2017 BMJ study comparing quality of care between US and foreign-trained doctors. The flaws in the study offer…
Addressing barriers to clinical trial accrual in patients with lung cancer: A survey based approach
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Scientific Bites – Cancer research e-learning platform
Plataforma de e-learning en oncología de precisión para investigadores. Plataforma de e-learning en oncología de precisión para investigadores. En FUNDACIÓN SOLTI utilizamos cookies de análisis…
Home | Ask Doctor Ed
He’s called Dr. Ed — that’s Edward T. Creagan, MD, a cancer specialist, the first Mayo Clinic doctor board certified in hospice and palliative medicine.…
Campus remembers Dr. Cowan, former director of cancer center
Services set for Tuesday for Ken Cowan, MD, PhD, whose ‘legacy will be felt for generations.’
European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
Sorry, I don’ t understand. Please try again This multitargeted, chemotherapy-free combination demonstrated superiority over osimertinib monotherapy for the first-line treatment of patients with EGFR-mutated…
Foreign-trained vs US-trained doctors
A public health leader recently cited a 2017 BMJ study comparing quality of care between US and foreign-trained doctors. The flaws in the study offer…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation
Aim: The “2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery” provides recommendations to guide clinicians in the perioperative cardiovascular evaluation and management of…
